CLINICAL_TRIALS
trial_result
· 2010-02-09
Clinical Trial Update: Phase I Trial of an Investigational Small Pox Medication [Phase 1]
Summary
Phase I study of SIGA Technologies' investigational smallpox antiviral tecovirimat (ST-246) has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SIGA Technologies | Conditions: Orthopoxviral Disease, Smallpox | Phase 1 | Status: COMPLETED | Results posted: 2010-02-09